| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |